But despite the stepped-up enforcement and recent settlements by Eli
Lilly and Pfizer, the industry continues to market antipsychotics aggressively. Wilson wonders how drugs approved by the Food and Drug Administration for about 1% of the population have become the
industry's biggest sellers and finds a simple answer.
"It's the money," Dr. Jerome L. Avorn, a Harvard medical professor and researcher, tells him. "When you're selling $1 billion a
year or more of a drug, it's very tempting for a company to just ignore the traffic ticket and keep speeding."
Wilson goes on to detail exactly how the companies have skirted the law. But the CEOs of both Eli Lilly and Pfizer aver that their companies' wayward days are behind them. "That was a blemish for us," says Eli Lilly's John C. Lechleiter. "We don't ever want that to happen again."
advertisement
advertisement